Quote | Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)
Last: | $21.55 |
---|---|
Change Percent: | 0.0% |
Open: | $21.55 |
Close: | $21.55 |
High: | $21.59 |
Low: | $21.45 |
Volume: | 6,089,181 |
Last Trade Date Time: | 06/03/2024 03:00:00 am |
News | Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)
Acquisition of Fusion Pharmaceuticals Completed Canada NewsWire HAMILTON , ON and BOSTON , June 4, 2024 /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs), a...
2024-05-31 18:06:40 ET More on AstraZeneca, Fusion Pharmaceuticals, etc. AstraZeneca: Plotting A Bold Path To $80 Billion Revenues, I'm Pausing For Breath AstraZeneca: A Triple Shot Of Income, Growth, And Value AstraZeneca: Strong In A Weak Market Amgen wins ...
Message Board Posts | Fusion Pharmaceuticals Inc. (NASDAQ:FUSN)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $FUSN News Article - Fusion Pharmaceuticals Announces IND Clearance for FPI-2068, a Joi | whytestocks | investorshangout | 04/12/2023 8:15:45 PM |
znewcar1: $SKYT 22% v3,0M C13.98 f43,285M H15.33 ML2.93 | znewcar1 | investorshangout | 02/14/2023 10:59:56 PM |
whytestocks: $FUSN News Article - Fusion Pharmaceuticals to Acquire Phase 2 Program for 225Ac-PSMA I | whytestocks | investorshangout | 02/13/2023 9:15:48 PM |
whytestocks: $FUSN News Article - Fusion Pharmaceuticals Reports Progress and Provides Recent Corpor | whytestocks | investorshangout | 01/06/2023 6:55:52 PM |
whytestocks: $FUSN News Article - Fusion Pharmaceuticals Announces Third Quarter 2022 Financial Resu | whytestocks | investorshangout | 11/08/2022 3:35:50 PM |
News, Short Squeeze, Breakout and More Instantly...
Fusion Pharmaceuticals Inc. Company Name:
FUSN Stock Symbol:
NASDAQ Market:
Fusion Pharmaceuticals Inc. Website:
Acquisition of Fusion Pharmaceuticals Completed Canada NewsWire HAMILTON , ON and BOSTON , June 4, 2024 /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs), a...
Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement Canada NewsWire HAMILTON , ON and BOSTON , May 31, 2024 /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation ...
Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca Canada NewsWire HAMILTON, ON and BOSTON , May 29, 2024 /CNW/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiocon...